daratumumab

Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Motley Fool
Mon, 02/10/20 - 11:32 pm
JNJ
Janssen
Darzalex
daratumumab
Multiple Myeloma
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
MorphoSys Settles Patent Lawsuit with Janssen and Genmab
CP Wire
Fri, 02/1/19 - 09:44 am
MorphoSys
Janssen
Genmab
daratumumab
patents
Johnson & Johnson Seeks EU and US Label Expansion for Darzalex
Market Realist
Thu, 09/13/18 - 11:34 am
JNJ
Janssen
Darzalex
daratumumab
Europe
Multiple Myeloma
Genmab gains on promising early success for daratumumab PhIII in multiple myeloma, but questions linger
Endpoints
Fri, 08/25/17 - 09:49 am
Genmab
daratumumab
Darzalex
Multiple Myeloma
clinical trials
Johnson & Johnson Courting Huge Revenue Potential In Multiple Myeloma Space
Seeking Alpha
Tue, 06/7/16 - 11:12 am
JNJ
Multiple Myeloma
daratumumab
ASCO 2016
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
Fierce Biotech
Mon, 11/16/15 - 03:29 pm
JNJ
Multiple Myeloma
daratumumab
FDA
Darzalex
Genmab
4 Things Johnson & Johnson Should Address When it Reports Its Q3 Results
Motley Fool
Sat, 10/10/15 - 09:09 am
JNJ
earnings
Invokana
daratumumab
devices
Bristol-Myers, J&J Upgraded On New Drug Prospects
Investors.com
Tue, 09/29/15 - 10:27 pm
Bristol-Myers Squibb
JNJ
Imbruvica
Opdivo
daratumumab
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Is This Johnson & Johnson's Next Blockbuster?
Investopedia
Wed, 06/10/15 - 09:50 pm
JNJ
Multiple Myeloma
daratumumab
Genmab shares rise on cancer drug's FDA license application
Yahoo/Reuters
Mon, 06/8/15 - 10:07 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Your ASCO15 guide: A mixed bag for Bristol-Myers, big wins for Merck, J&J
BioPharma Dive
Sun, 05/31/15 - 11:21 am
ASCO
Bristol-Myers Squibb
JNJ
Merck
Keytruda
Opdivo
daratumumab
J&J multiple myeloma drug offers hope after others stop working -study
Yahoo/Reuters
Sat, 05/30/15 - 11:55 am
JNJ
Multiple Myeloma
ASCO
daratumumab
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 04:13 pm
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Pipeline Review
Sat, 07/19/14 - 09:26 am
daratumumab
Multiple Myeloma
J&J hands over $25M milestone for daratumumab progress
Fierce Biotech
Mon, 07/7/14 - 11:25 am
JNJ
daratumumab
Genmab
Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tue, 11/26/13 - 09:00 am
Genmab
daratumumab
JNJ
Janssen

Pages